Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Paradoxical effects of tumour necrosis factor-alpha in adjuvant-induced arthritis.

    Williams RO.

    Arthritis Res Ther. 2008;10(3):113. Epub 2008 Jun 6.

    PMID:
    18564403
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritis.

    Kim EY, Chi HH, Rajaiah R, Moudgil KD.

    Arthritis Res Ther. 2008 Apr 1;10(1):R38.

    PMID:
    18380898
    [PubMed - indexed for MEDLINE]
    3.

    Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.

    Boettger MK, Hensellek S, Richter F, Gajda M, Stöckigt R, von Banchet GS, Bräuer R, Schaible HG.

    Arthritis Rheum. 2008 Aug;58(8):2368-78.

    PMID:
    18668541
    [PubMed - indexed for MEDLINE]
    Free Article
    4.
    5.

    Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production.

    Haynes DR, Gadd SJ, Whitehouse MW, Mayrhofer G, Vernon-Roberts B.

    Inflamm Res. 1996 Apr;45(4):159-65.

    PMID:
    8741004
    [PubMed - indexed for MEDLINE]
    6.

    Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats.

    Feige U, Hu YL, Gasser J, Campagnuolo G, Munyakazi L, Bolon B.

    Cell Mol Life Sci. 2000 Sep;57(10):1457-70.

    PMID:
    11078023
    [PubMed - indexed for MEDLINE]
    7.

    TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.

    Mukherjee P, Wu B, Mayton L, Kim SH, Robbins PD, Wooley PH.

    Ann Rheum Dis. 2003 Aug;62(8):707-14.

    PMID:
    12860724
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation.

    Boettger MK, Weber K, Grossmann D, Gajda M, Bauer R, Bär KJ, Schulz S, Voss A, Geis C, Bräuer R, Schaible HG.

    Arthritis Rheum. 2010 May;62(5):1308-18.

    PMID:
    20213802
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis.

    Geboes L, De Klerck B, Van Balen M, Kelchtermans H, Mitera T, Boon L, De Wolf-Peeters C, Matthys P.

    Arthritis Rheum. 2007 Aug;56(8):2595-607.

    PMID:
    17665444
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.

    Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A, De Fougerolles AR, Sprague A, Browning JL.

    J Immunol. 2003 Jul 1;171(1):115-26.

    PMID:
    12816989
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate.

    Kong JS, Yoo SA, Kim HS, Kim HA, Yea K, Ryu SH, Chung YJ, Cho CS, Kim WU.

    Arthritis Rheum. 2010 Jan;62(1):159-70.

    PMID:
    20039434
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.

    Schuerwegh AJ, Van Offel JF, Stevens WJ, Bridts CH, De Clerck LS.

    Rheumatology (Oxford). 2003 Apr;42(4):541-8.

    PMID:
    12649401
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.

    Edwards CK 3rd, Bendele AM, Reznikov LI, Fantuzzi G, Chlipala ES, Li L, Moldawer LL, Mountz JD, Li YY, Dinarello CA.

    Arthritis Rheum. 2006 Sep;54(9):2872-85.

    PMID:
    16947419
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.

    Radovits BJ, Kievit W, Laan RF.

    Drugs Aging. 2009;26(8):647-64. doi: 10.2165/11316460-000000000-00000. Review.

    PMID:
    19685931
    [PubMed - indexed for MEDLINE]
    15.

    Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A.

    Ayer LM, Issekutz AC, Waterhouse CC, Stadnyk AW.

    Inflammation. 2000 Oct;24(5):447-61.

    PMID:
    10921508
    [PubMed - indexed for MEDLINE]
    16.

    Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators.

    Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26. Erratum in: Lancet. 2009 Oct 24;374(9699):1422.

    PMID:
    19560810
    [PubMed - indexed for MEDLINE]
    17.

    Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.

    Santora K, Rasa C, Visco D, Steinetz BG, Bagnell CA.

    J Pharmacol Exp Ther. 2007 Aug;322(2):887-93. Epub 2007 May 25.

    PMID:
    17526806
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.

    Miwatashi S, Arikawa Y, Kotani E, Miyamoto M, Naruo K, Kimura H, Tanaka T, Asahi S, Ohkawa S.

    J Med Chem. 2005 Sep 22;48(19):5966-79.

    PMID:
    16162000
    [PubMed - indexed for MEDLINE]
    19.

    A novel anti-rheumatic drug suppresses tumor necrosis factor-alpha and augments interleukin-10 in adjuvant arthritic rats.

    Hisadome M, Fukuda T, Sumichika H, Hanano T, Adachi K.

    Eur J Pharmacol. 2000 Dec 15;409(3):331-5.

    PMID:
    11108829
    [PubMed - indexed for MEDLINE]
    20.

    The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.

    Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BA, Tak PP.

    Ann Rheum Dis. 2008 Aug;67(8):1139-44. Epub 2007 Nov 29.

    PMID:
    18055470
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk